Genus Plc (Genus) is an animal genetics company. It primarily carries out the advancing animal breeding and genetic improvement through the application of biotechnology. The company sells value-added products for livestock farming and food producers, with its technology being applicable across livestock species. Genus operates in the dairy, beef, and pork food production sectors, with its products being sold in over 80 countries. The company's products include semen, embryos, and breeding animals with superior genetics. Genus's customers use these products to produce offspring with greater production efficiency and quality, thereby supplying the global dairy and meat supply chains.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Genus focus on using cutting-edge science and technology to assist farmers in breeding animals with desired traits such as feed conversion efficiency, disease resistance, and faster growth. The company employs genome science, biosystems engineering, advanced reproductive techniques, and responsible gene editing to accelerate genetic improvement, contributing to a more sustainable food system by enabling the production of safe, affordable, and high-quality animal protein with fewer natural resource. The company's R&D initiatives include understanding the links between DNA and animal characteristics, breeding successive generations of animals using DNA analysis, creating the technology platform IntelliGen Technologies, and developing pigs resistant to PRRSv through gene editing. The company also focuses on sustainability efforts and has been building knowledge about animal breeding and genetics for decades. Genus undertakes research with the aim of gaining new scientific or technical knowledge and capitalizes further development costs within intangible assets when research projects achieve technical feasibility and are commercially viable. The R&D units of Genus include Genomic Science, Data Science, Biosystems Engineering, Trait Development, and Reproductive Biology. Genomic Science develops and provides foundational genomic knowledge about livestock animals for genetic improvement. Data Science combines various data streams and makes the information available for R&D to optimize processes within product development and research teams. Biosystems Engineering integrates engineering science and design with applied biological and environmental sciences. Trait Development applies the latest and safest technologies focusing on disease-resistance in animals. Reproductive Biology focuses on the development and commercial application of advanced reproductive techniques. In FY2025, the company spent GBP16.5 million on its R&D activities, which as a percentage of its sales stood at 2.4%.